Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity of Pneumococcal Vaccine in Liver Transplant Recipients Using a Conjugate-Polysaccharide Priming-Booster Strategy

NCT00152802 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT00152802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00152802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity of Pneumococcal Vaccine in Liver Transplant Recipients Using a Conjugate-Polysaccharide Priming-Booster Strategy
Lead sponsor
University Health Network, Toronto
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2005
Completion date
January 31, 2009
Enrollment
130
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

transplant